MOLECULAR PARTNERS AG -ADR
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About MOLN
Molecular Partners AG is a Switzerland-based company engaged in the pharmaceuticals industry. As a biopharmaceutical company, it is active in the research and development of proteins like DARPins (Designed Ankyrin Repeat Proteins), a new class of small proteins used for the development of medicine against diseases like cancer and sight-threating diseases, among others. The Company’s pipeline is structured mainly through three areas: Ophthalmology, including the creation of therapies for renital diseases like wet age-related macular degeration (wet AMD) and diabetic macular edema (DME); Oncology, containing the development of DARPins against cancer, among others; and Immunology and other Indications, entailing DARPins against several targets important for the treatment of inflammatory and auto-immune diseases.
Find out what a historical investment in MOLECULAR PARTNERS AG -ADR would be worth today using our MOLN stock calculator.
$167.97M
-
0.00%
1.09K
$4.47
$4.46
$4.47
$5.36
$3.36
Ready to start your investing journey with Stake?
Open an accountMOLN FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MOLN
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MOLN
on Stake
Buy MOLN from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of MOLN from only US$10 with fractional shares
